医疗质量研究理论概述与脑血管病实践

doi:10.3969/j.issn.1673-5765.2024.12.016

摘要/Abstract

摘要： 医疗质量是重要的公共卫生问题之一，事关民生福祉。脑血管病是位列我国疾病负担第一的疾病。目前的脑血管病医疗质量研究和行动缺乏系统的理论指导框架。本文从医疗质量的概念、指标选取、数据来源与常用理论模型几方面进行介绍，并列举了脑血管病医疗质量研究实践案例，构建了由理论到实践的完整框架，期望为脑血管病领域的医疗质量改进提供较为清晰的理论帮助与实践参考。

关键词: 医疗质量; 脑血管病; 卒中; 理论; 实践

Abstract: Medical quality is one of the most important public health problems, profoundly impacting public well-being. Cerebrovascular diseases rank first in China’s disease burden. Current research and actions on the medical quality of cerebrovascular diseases lack a systematic theoretical guidance framework. This paper introduces the concept of medical quality, the selection of relevant indicators, data sources, and commonly used theoretical models. It enumerates practical cases of medical quality research on cerebrovascular diseases and constructs a complete framework from theory to practice. This paper aims to provide clear theoretical assistance and practical references for improving the medical quality in the field of cerebrovascular diseases.

Key words: Medical quality; Cerebrovascular disease; Stroke; Theory; Practice

中图分类号:

闫皓宇, 王春娟, 杨昕, 翟屹, 李子孝, 谷鸿秋. 医疗质量研究理论概述与脑血管病实践[J]. 中国卒中杂志, 2024, 19(12): 1486-1494.

YAN Haoyu, WANG Chunjuan, YANG Xin, ZHAI Yi, LI Zixiao, GU Hongqiu. Overview of Medical Quality Research Theory and Practice in Cerebrovascular Diseases[J]. Chinese Journal of Stroke, 2024, 19(12): 1486-1494.

参考文献

[1] World Health Organization. Handbook for national quality policy and strategy：a practical approach for developing policy and strategy to improve quality of care[EB/OL]. [2024-11-19]. https://www.who.int/publications/i/item/9789241565561.
[2] KRUK M E，GAGE A D，ARSENAULT C，et al. High-quality health systems in the sustainable development goals era：time for a revolution[J/OL]. Lancet Glob Health，2018，6（11）：e1196-e1252[2024-11-19]. https://doi.org/10.1016/S2214-109X（18）30386-3.
[3] GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations，1990—2021：a systematic analysis for the global burden of disease study 2021[J]. Lancet，2024，403（10440）：2162-2203.
[4] DONABEDIAN A. Explorations in quality assessment and monitoring：the definition of quality and approaches to its assessment[Z]. Health Administration Press，1980.
[5] COUNCIL OF EUROPE. The development and implementation of quality improvement systems（QIS）in health care—recommendation No.R（97）17 and explanatory memorandum[EB/OL]. [2024-11-19]. https://book.coe.int/en/health-and-society-ethics/607-the-development-and-implementation-of-quality-improvement-systems-qis-in-health-care-recommendation-no-r-97-17-and-explanatory-memorandum.html.
[6] Institute of Medicine（US）Committee to Design a Strategy for Quality Review and Assurance in Medicare. Medicare：a strategy for quality assurance：volume Ⅱ sources and methods[M]. Washington，DC：National Academies Press，1990.
[7] ARAH O A，WESTERT G P，HURST J，et al. A conceptual framework for the OECD health care quality indicators project[J/OL]. Int J Qual Health Care，2006，18 Suppl 1：5-13[2024-11-19]. https://doi.org/10.1093/intqhc/mzl024.
[8] Agency for Healthcare Research and Quality. Best practices in public reporting No.2：maximizing consumer understanding of public comparative quality reports：effective use of explanatory information[EB/OL]. [2024-11-29]. https://www.ahrq.gov/ncepcr/tools/public-reporting/guide2.html.
[9] BUSSE R，KLAZINGA N，PANTELI D，et al. Improving healthcare quality in Europe：characteristics，effectiveness and implementation of different strategies[M]. Copenhagen，Denmark：WHO Regional Office for Europe，2019.
[10] 国家统计局. 行政记录数据是如何应用于统计工作的[EB/OL]. [2024-12-04]. https://www.stats.gov.cn/zs/tjws/tjdc/202302/t20230215_1907657. html.
[11] DAMSCHRODER L J，REARDON C M，WIDERQUIST M A O，et al. The updated consolidated framework for implementation research based on user feedback[J/OL]. Implement Sci，2022，17（1）：75[2024-11-19]. https://doi.org/10.1186/s13012-022-01245-0.
[12] FANG J M，KAPRAL M K，RICHARDS J，et al. The registry of Canadian stroke network：an evolving methodology[J]. Acta Neurologica Taiwanica，2011，20（2）：77-84.
[13] WANG Y J，LI Z X，WANG Y L，et al. Chinese Stroke Center Alliance：a national effort to improve healthcare quality for acute stroke and transient ischaemic attack：rationale，design and preliminary findings[J]. Stroke Vasc Neurol，2018，3（4）：256-262.
[14] GU H Q，YANG X，WANG C J，et al. Clinical characteristics，management，and in-hospital outcomes in patients with stroke or transient ischemic attack in China[J/OL]. JAMA Network Open，2021，4（8）：e2120745[2024-11-19]. https://doi.org/10.1001/jamanetworkopen.2021.20745.
[15] DONABEDIAN A. Evaluating the quality of medical care[J]. Milbank Mem Fund Q，1966，44（3）：166-206.
[16] DONABEDIAN A. The quality of care：how can it be assessed？[J]. JAMA，1988，260（12）：1743-1748.
[17] TAYLOR M J，MCNICHOLAS C，NICOLAY C，et al. Systematic review of the application of the plan-do-study-act method to improve quality in healthcare[J]. BMJ Qual Saf，2014，23（4）：290-298.
[18] GLASGOW R E，VOGT T M，BOLES S M. Evaluating the public health impact of health promotion interventions：the RE-AIM framework[J]. Am J Public Health，1999，89（9）：1322-1327.
[19] GRAHAM I D，LOGAN J，HARRISON M B，et al. Lost in knowledge translation：time for a map？[J]. J Contin Educ Health Prof，2006，26（1）：13-24.
[20] DAMSCHRODER L J，ARON D C，KEITH R E，et al. Fostering implementation of health services research findings into practice：a consolidated framework for advancing implementation science[J/OL]. Implement Sci，2009，4：50[2024-11-19]. https://doi.org/10.1186/1748-5908-4-50.
[21] American Heart Association. Get with the guidelines[EB/OL]. [2024-11-22]. https://www.heart.org/en/professional/quality-improvement/get-with-the-guidelines.
[22] SHEN Y，CHAO B H，CAO L，et al. Stroke center care and outcome：results from the CSPPC stroke program[J]. Transl Stroke Res，2020，11（3）：377-386.
[23] TU W J，WANG L D. China stroke surveillance report 2021[J/OL]. Mil Med Res，2023，10（1）：33[2024-11-19]. https://doi.org/10.1186/s40779-023-00463-x.
[24] FONAROW G C，ZHAO X，SMITH E E，et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative[J]. JAMA，2014，311（16）：1632-1640.
[25] HAESEBAERT J，NIGHOGHOSSIAN N，MERCIER C，et al. Improving access to thrombolysis and inhospital management times in ischemic stroke：a stepped-wedge randomized trial[J]. Stroke，2018，49（2）：405-411.
[26] WANG Y L，LI Z X，ZHAO X Q，et al. Effect of a multifaceted quality improvement intervention on hospital personnel adherence to performance measures in patients with acute ischemic stroke in China：a randomized clinical trial[J]. JAMA，2018，320（3）：245-254.
[27] LEVI C R，ATTIA J A，D’ESTE C，et al. Cluster-randomized trial of thrombolysis implementation support in metropolitan and regional Australian stroke centers：lessons for individual and systems behavior change[J/OL]. J Am Heart Assoc，2020，9（3）：e012732[2024-11-19]. https://doi.org/10.1161/JAHA.119.012732.
[28] PRICE C I，SHAW L，ISLAM S，et al. Effect of an enhanced paramedic acute stroke treatment assessment on thrombolysis delivery during emergency stroke care：a cluster randomized clinical trial[J]. JAMA neurology，2020，77（7）：840-848.
[29] WANG C J，GU H Q，ZONG L X，et al. Effectiveness of a quality improvement intervention on reperfusion treatment for patients with acute ischemic stroke：a stepped-wedge cluster randomized clinical trial[J/OL]. JAMA Netw Open，2023，6（6）：e2316465[2024-11-19]. https://doi.org/10.1001/jamanetworkopen.2023.16465.
[30] MIAO Z. Work flow improvement in pre-procedural management of acute ischemic stroke with endovascular treatment：a multi-centre，cluster randomised，open label，parallel controlled study：NCT04151589[R/OL]. clinicaltrials. gov，2019[2024-10-21]. https://www.clinicaltrials.gov/study/NCT04151589.
[31] ZHONG W S，LIN L T，GONG X X，et al. Evaluation of a multicomponent intervention to shorten thrombolytic door-to-needle time in stroke patients in China（MISSION）：a cluster-randomized controlled trial[J/OL]. PLoS Med，2022，19（7）：e1004034[2024-11-19]. https://doi.org/10.1371/journal.pmed.1004034.
[32] LOWTHER H J，HARRISON J，HILL J E，et al. The effectiveness of quality improvement collaboratives in improving stroke care and the facilitators and barriers to their implementation：a systematic review[J/OL]. Implement Sci，2021，16（1）：95[2024-11-19]. https://doi.org/10.1186/s13012-021-01162-8.
[33] 国家神经系统疾病医疗质量控制中心脑血管病质控专病组. 脑梗死医疗质量控制指标（2020年版）[J]. 中国卒中杂志，2024，19（1）：35-43.
The Cerebrovascular Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases. Medical quality control indicators for cerebral infarction（2020 edition）[J]. Chin J Stroke，2024，19（1）：35-43.